Strategic partnerships Global distribution partnerships and recent collaboration activity (Xograph Healthcare, Endovascular Navigation partnerships, and integration with other industry players) indicate ongoing channel expansion opportunities to reach new geographies and hospitals.

Product expansion Recent product line growth such as the Ziehm Solo FD and upcoming vascular software releases signal opportunities to upsell advanced imaging capabilities to current customers while attracting new accounts seeking cutting-edge intraoperative imaging.

Clinical adoption Active participation in major conferences (ECR 2025, Charing Cross Symposium) and validation milestones with partners (Body Vision, LungVision) suggest a favorable environment for trial deployments and case-based selling to interventional suites.

Digital readiness Seamless digital network integration and expertise in dose reduction underscore the value proposition for hospitals pursuing value-based care and improved OR efficiency, helping to position Ziehm as a preferred vendor for digital integration and safety improvements.

Growth potential Healthy yet modest revenue scale (sub-$10M) combined with a broad addressable market in mobile C-arm imaging (interventional, vascular, neuro-spine, orthopedics) presents a clear target for solution-led selling, expansions into new regional accounts, and cross-sell of software and service packages.